NOTARFRANCHI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 224
EU - Europa 172
AS - Asia 56
AF - Africa 7
OC - Oceania 1
Totale 460
Nazione #
US - Stati Uniti d'America 221
IT - Italia 41
IE - Irlanda 40
SE - Svezia 38
CN - Cina 33
SG - Singapore 18
FR - Francia 15
DE - Germania 14
AT - Austria 5
CI - Costa d'Avorio 5
CZ - Repubblica Ceca 5
FI - Finlandia 5
RU - Federazione Russa 4
CA - Canada 3
IN - India 2
TR - Turchia 2
AU - Australia 1
BG - Bulgaria 1
GB - Regno Unito 1
IR - Iran 1
LU - Lussemburgo 1
NG - Nigeria 1
NL - Olanda 1
RO - Romania 1
SC - Seychelles 1
Totale 460
Città #
Chandler 63
Dublin 40
Boardman 21
Ashburn 19
Shanghai 19
Marseille 12
Singapore 12
Parma 11
New York 8
Munich 7
Ann Arbor 6
Beijing 6
Bremen 6
Princeton 6
Abidjan 5
Fairfield 5
Vienna 5
Brno 4
Helsinki 4
San Mateo 4
Santa Clara 4
Bologna 3
Cesena 3
Des Moines 3
Los Angeles 3
Reggio Emilia 3
Rome 3
Fremont 2
Kocaeli 2
Medesano 2
Norwalk 2
Ottawa 2
Palermo 2
Piacenza 2
Pune 2
Seattle 2
Shenyang 2
West Jordan 2
Wilmington 2
Augusta 1
Castel San Giovanni 1
Catania 1
Charlotte 1
Dallas 1
Denver 1
Focsani 1
Gatchina 1
Hangzhou 1
Lagos 1
Leawood 1
London 1
Lurate Caccivio 1
Milan 1
Montesilvano 1
Moscow 1
Naples 1
Nerviano 1
Phoenix 1
Sabz 1
Sofia 1
Sydney 1
Tampa 1
Toronto 1
Turku 1
Waltham 1
Washington 1
Totale 336
Nome #
Application of next-generation sequencing for the genomic characterization of patients with smoldering myeloma 85
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients 69
Concomitant primary hyperparathyroidism in patients with multiple myeloma: A possible link? 58
Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma 56
Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results 54
Combining bortezomib to high dose melphalan as conditioning regimen results in the improvement of the response rate in newly diagnosed young multiple myeloma patients 54
The impact of CD56 expression in smoldering myeloma patients on early progression 39
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response 23
Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma 20
CD38 expression by plasma cells in extramedullary multiple myeloma 15
IMPACT OF TREATMENT WITH IDELALISIB PLUS RITUXIMAB ON CLINICAL AND CYTOGENETICS PROFILE IN RELAPSE/REFRACTORY CLL: THE EXPERIENCE OF THE UNIVERSITY HOSPITAL OF PARMA 9
Totale 482
Categoria #
all - tutte 2.508
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.508


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 0 0 2 1 0 0
2020/202148 13 0 1 1 4 0 1 5 2 10 5 6
2021/202251 0 4 3 2 0 0 11 5 1 2 0 23
2022/2023203 22 24 18 19 10 22 9 12 49 5 7 6
2023/2024119 4 7 1 4 9 25 14 2 5 8 13 27
2024/202558 12 11 21 14 0 0 0 0 0 0 0 0
Totale 482